• Home
  • News
  • Fortune 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia

That Aldus portfolio data (some of) you asked for…

By
Dan Primack
Dan Primack
Down Arrow Button Icon
By
Dan Primack
Dan Primack
Down Arrow Button Icon
December 22, 2010, 9:36 PM ET

Earlier this week I wrote about the relationship between Deutsche Bank and Aldus Equity, a Dallas-based private equity manager that collapsed after becoming embroiled in multiple pay-to-play scandals. My primary on-the-record source was former Aldus principal Marcellus Taylor, who says that Deutsche threatened to end investment talks with Aldus if it didn’t reinstate the firm’s founder (who since has plead guilty to felony securities fraud).

Late in the story, I mentioned that Taylor spoke with Fortune after we “obtained, and partially published, a confidential offering document recently circulated by Taylor, in which he is seeking to sell his personal stake in an Aldus co-investment vehicle.”

A few readers emailed to say: “Where did you publish it? I can’t find it on the website.”

I should have been a bit clearer: It was partially published in the Term Sheet’s daily email (sign up here). More specifically, we published some internal rates of return (IRRs) from a $54 million Aldus co-investment fund that backed a number of leveraged buyouts and VC deals between 2005 and 2007.

For the sake of keeping everything in one place, I’ve published them below (data through 12/31/09). In aggregate, Taylor is looking to sell his piece of the general partnership for just 26 cents on the dollar.

  • Advanstar Communications (VSS, Citi, NY Life Capital): -57% IRR
  • Claire’s (Apollo, Tri-Artisan Capital): -12.8% IRR
  • Growing Family (Falconhead Capital Partners): -35.4% IRR
  • TMP Worldwide (VSS): 105.4% IRR
  • Entertainment Cruises (ICV Capital): 18.7% IRR
  • U.S. Foodservice (CD&R): Being carried at cost
  • Simeus Foods (Levine Leichtman Captial): Being carried at cost
  • Hertz (publicly-traded, CD&R/Carlyle): 129.5% IRR
  • Javelin Pharmaceuticals (publicly-traded, Goldman Sachs, NGN Biopharma Ventures): -12.6% IRR
About the Author
By Dan Primack
See full bioRight Arrow Button Icon

Latest in

InnovationBrainstorm Design
Procurement execs often don’t understand the value of good design, experts say
By Angelica AngDecember 8, 2025
27 minutes ago
Personal Financemortgages
Current mortgage rates report for Dec. 8, 2025: Rates hold steady with Fed meeting on horizon
By Glen Luke FlanaganDecember 8, 2025
1 hour ago
Personal FinanceReal Estate
Current ARM mortgage rates report for Dec. 8, 2025
By Glen Luke FlanaganDecember 8, 2025
1 hour ago
Personal FinanceReal Estate
Current refi mortgage rates report for Dec. 8, 2025
By Glen Luke FlanaganDecember 8, 2025
1 hour ago
CryptoBinance
Binance has been proudly nomadic for years. A new announcement suggests it’s finally chosen a headquarters
By Ben WeissDecember 7, 2025
5 hours ago
Big TechStreaming
Trump warns Netflix-Warner deal may pose antitrust ‘problem’
By Hadriana Lowenkron, Se Young Lee and BloombergDecember 7, 2025
9 hours ago

Most Popular

placeholder alt text
Real Estate
The 'Great Housing Reset' is coming: Income growth will outpace home-price growth in 2026, Redfin forecasts
By Nino PaoliDecember 6, 2025
2 days ago
placeholder alt text
AI
Nvidia CEO says data centers take about 3 years to construct in the U.S., while in China 'they can build a hospital in a weekend'
By Nino PaoliDecember 6, 2025
2 days ago
placeholder alt text
Economy
The most likely solution to the U.S. debt crisis is severe austerity triggered by a fiscal calamity, former White House economic adviser says
By Jason MaDecember 6, 2025
1 day ago
placeholder alt text
Economy
JPMorgan CEO Jamie Dimon says Europe has a 'real problem’
By Katherine Chiglinsky and BloombergDecember 6, 2025
1 day ago
placeholder alt text
Politics
Supreme Court to reconsider a 90-year-old unanimous ruling that limits presidential power on removing heads of independent agencies
By Mark Sherman and The Associated PressDecember 7, 2025
17 hours ago
placeholder alt text
Big Tech
Mark Zuckerberg rebranded Facebook for the metaverse. Four years and $70 billion in losses later, he’s moving on
By Eva RoytburgDecember 5, 2025
3 days ago
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.